Back
KalVista Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
KALV
Sponsored
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Buy
51
KALV
KalVista Pharmaceuticals
Last Price:
9.11
Seasonality Move:
13.48%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)KalVista Pharmaceuticals Price Quote
$9.11
-0.33 (-3.5%)
(Updated: December 11, 2024 at 5:55 PM ET)
KalVista Pharmaceuticals Key Stats
Buy
51
KalVista Pharmaceuticals (KALV)
is a Buy
Day range:
$9.13 - $9.59
52-week range:
$8.19 - $16.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
31.82
P/B ratio:
3.48%
Volume:
247.6K
Avg. volume:
411.4K
1-year change:
15.69%
Market cap:
$466.5M
Revenue:
$0
EPS:
$-3.69
How Much Does KalVista Pharmaceuticals Make?
Data Unavailable
Is KalVista Pharmaceuticals Growing As A Company?
Data Unavailable
KalVista Pharmaceuticals Stock Price Performance
-
Did KalVista Pharmaceuticals Stock Go Up Last Month?
KalVista Pharmaceuticals share price went down by -17.27% last month -
Did KALV's Share Price Rise Over The Last Year?
KALV share price rose by 15.69% over the past 1 year
What Is KalVista Pharmaceuticals 52-Week High & Low?
-
What Is KalVista Pharmaceuticals’s 52-Week High Share Price?
KalVista Pharmaceuticals has traded as high as $16.88 over the past 52 weeks -
What Is KalVista Pharmaceuticals’s 52-Week Low Share Price?
KalVista Pharmaceuticals has traded as low as $8.19 over the past 52 weeks
KalVista Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy KalVista Pharmaceuticals?
-
How Much Debt Does KalVista Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does KalVista Pharmaceuticals Have?
Cash and short term investments quarterly total is $135.8M -
What Is KalVista Pharmaceuticals’s Book Value Per Share?
Book value per share is 3.10
Is KalVista Pharmaceuticals Cash Flow Positive?
-
What Is KALV Cash Flow From Operations?
Cash flow from operations (TTM) is -$122.5M -
What Is KalVista Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $153.7M -
What Is KalVista Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$47.1M
KalVista Pharmaceuticals Return On Invested Capital
Data Unavailable
KalVista Pharmaceuticals Earnings Date & Stock Price
-
What Is KalVista Pharmaceuticals's Stock Price Today?
A single share of KALV can be purchased today for 9.44 -
What Is KalVista Pharmaceuticals’s Stock Symbol?
KalVista Pharmaceuticals trades on the nasdaq under the ticker symbol: KALV -
When Is KalVista Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for KalVista Pharmaceuticals is scheduled on March 11, 2025 -
When Is KALV's next ex-dividend date?
KalVista Pharmaceuticals's next ex-dividend date is December 12, 2024 -
How To Buy KalVista Pharmaceuticals Stock?
You can buy KalVista Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
KalVista Pharmaceuticals Competitors
-
Who Are KalVista Pharmaceuticals's Competitors?
Below is a list of companies who compete with KalVista Pharmaceuticals or are related in some way:
KalVista Pharmaceuticals Dividend Yield
-
What Is KALV Dividend Yield?
KalVista Pharmaceuticals’s dividend yield currently is 0% -
What Is KalVista Pharmaceuticals’s Payout Ratio?
KalVista Pharmaceuticals’s payout ratio is 0% -
When Did KalVista Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is December 12, 2024 -
What Is KalVista Pharmaceuticals’s Dividend Per Share?
KalVista Pharmaceuticals pays a dividend of $0.00 per share
KalVista Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -0.22% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 28.50 |
Upside from Last Price: | 201.91% |